Bay Street News, February, 2024

Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development […]

BRISBANE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on […]

Dallas, Texas, Feb. 28, 2024 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today announced that its board of directors […]

TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) — Aecon Group Inc. (TSX: ARE) (“Aecon”) announced today that Contrecoeur Terminal Constructors General […]

ROSEMONT, Ill., Feb. 28, 2024 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust” or the “Company”) (Nasdaq: WTFC) will present at […]

–   Petosemtamab in 1L HNSCC in combination with pembrolizumab initial interim clinical data planned for 2Q24; preparing for a potential […]

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) — AdTheorent Holding Company, Inc. (“AdTheorent” or the “Company”) (Nasdaq: ADTH), a machine […]

PALO ALTO, Calif, Feb. 28, 2024 (GLOBE NEWSWIRE) — HP (NYSE: HPQ) First quarter GAAP diluted net earnings per share […]

CALGARY, Alberta, Feb. 28, 2024 (GLOBE NEWSWIRE) — Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) announces fourth quarter and […]

EVANSVILLE, Ind., Feb. 28, 2024 (GLOBE NEWSWIRE) — Old National Bancorp (NASDAQ: ONB) today announced that Chairman and Chief Executive […]